RecruitingNCT07491952

Continuous Dual Aspiration Technique With Zoom System for Stroke

Clinical Evaluation of Continuous Dual Aspiration Technique With Zoom System for Stroke (ADAPT 2.0)

Sponsor

Imperative Care, Inc.

Enrollment

750 participants

Start Date

Mar 24, 2026

Study Type

OBSERVATIONAL

Conditions

Acute Stroke Ischemic Stroke

Summary

This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Zoom System for people with acute stroke and ischemic stroke. The study is currently recruiting participants at 13 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEZoom System

Aspiration neurothrombectomy using Zoom System with Continuous Dual Aspiration Technique (CDAT)

Locations(16)

Huntsville Hospital

Huntsville, Alabama, United States

John Muir Health

Walnut Creek, California, United States

University of South Florida

Tampa, Florida, United States

Ochsner Clinic Foundation

New Orleans, Louisiana, United States

University of Maryland

Baltimore, Maryland, United States

Allina Health

Minneapolis, Minnesota, United States

Albany Medical College

Albany, New York, United States

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

University of Oklahoma, Health Science Center

Oklahoma City, Oklahoma, United States

Prisma Health - Upstate

Greenville, South Carolina, United States

Semmes Murphey Foundation

Memphis, Tennessee, United States

HCA Houston Healthcare Kingwood

Kingwood, Texas, United States

Methodist Healthcare System of San Antonio

San Antonio, Texas, United States

University of Texas Science Health Center at San Antonio

San Antonio, Texas, United States

Inova Fairfax Medical Campus

Falls Church, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07491952

Related Trials

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

NCT0597668530 locations

STROKE 120 ACTION Trial

NCT071353101 location

Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy

NCT077135372 locations

Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke

NCT074057622 locations

Quantitative Net Water Uptake as a Predictor of Functional Outcomes After Intravenous Thrombolysis in Acute Ischemic Stroke International Multicenter Observational Retrospective Study

NCT072999811 location